Neoadjuvant Study of Pyrotinib in HER-2 Positive Breast Cancer
Clinical trial NCT04126525 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04126525
- Sponsor
- RenJi Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-18
- Primary completion
- 2021-10-28
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.